Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results

AIMS: This paper presents the treatment outcomes for patients intiated on biphasic insulin aspart 30 (BIAsp 30) treatment: BIAsp 30-only, BIAsp 30 + sulphonylureas (SU), BIAsp 30 + biguanides (BI), BIAsp 30 + SU + BI, BIAsp 30 + alpha-glucosidase inhibitors (GI), and BIAsp 30 + BI + thiazolidinedion...

Descripción completa

Detalles Bibliográficos
Autores principales: Güler, Serdar, Sharma, Surendra Kumar, Almustafa, Majeed, Kim, Chong Hwa, Azar, Sami, Danciulescu, Rucsandra, Shestakova, Marina, Khutsoane, Duma, Bech, Ole Molskov
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2009
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721962/
https://www.ncbi.nlm.nih.gov/pubmed/19684847
http://dx.doi.org/10.1111/j.1753-5174.2008.00015.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721962/
https://www.ncbi.nlm.nih.gov/pubmed/19684847
http://dx.doi.org/10.1111/j.1753-5174.2008.00015.x

Ejemplares similares